Falcon Point Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-9,679
| Closed | -$849K | – | 126 |
|
|
2018
Q1 | $849K | Sell |
9,679
-2,055
| -18% | -$180K | 0.17% | 76 |
|
|
2017
Q4 | $996K | Sell |
11,734
-9,336
| -44% | -$792K | 0.17% | 74 |
|
|
2017
Q3 | $1.76M | Sell |
21,070
-1,032
| -5% | -$86.3K | 0.26% | 61 |
|
|
2017
Q2 | $1.71M | Sell |
22,102
-4,568
| -17% | -$353K | 0.23% | 65 |
|
|
2017
Q1 | $1.85M | Buy |
26,670
+819
| +3% | +$56.8K | 0.25% | 61 |
|
|
2016
Q4 | $1.53M | Buy |
25,851
+770
| +3% | +$45.6K | 0.2% | 63 |
|
|
2016
Q3 | $1.41M | Buy |
25,081
+2,229
| +10% | +$125K | 0.22% | 63 |
|
|
2016
Q2 | $1.24M | Buy |
22,852
+2,552
| +13% | +$138K | 0.21% | 70 |
|
|
2016
Q1 | $1.05M | Buy |
20,300
+2,268
| +13% | +$117K | 0.18% | 75 |
|
|
2015
Q4 | $1.27M | Buy |
18,032
+1,217
| +7% | +$85.4K | 0.27% | 62 |
|
|
2015
Q3 | $1.05M | Sell |
16,815
-3,750
| -18% | -$233K | 0.37% | 69 |
|
|
2015
Q2 | $1.73M | Sell |
20,565
-72
| -0.3% | -$6.05K | 0.58% | 53 |
|
|
2015
Q1 | $1.55M | Buy |
20,637
+162
| +0.8% | +$12.2K | 1.21% | 31 |
|
|
2014
Q4 | $1.27M | Buy |
20,475
+3,192
| +18% | +$198K | 1.17% | 33 |
|
|
2014
Q3 | $899K | Buy |
+17,283
| New | +$899K | 0.76% | 52 |
|